Press Releases

April 23, 2021
Accolade to Acquire PlushCare
Accolade to begin offering virtual primary care and mental health consultations directly to members as a result of the acquisition. $200bn+ combined target addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and managing rising costs.
Additional Formats
March 25, 2021
Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering
SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal amount of 0.50% convertible senior notes due 2026 (the “Notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule
Additional Formats
March 23, 2021
Accolade Announces Private Offering of $250 Million Convertible Notes
SEATTLE, March 23, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced today that it intends to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible senior notes due 2026 (the “Notes”) in a private placement (the “offering”)
Additional Formats
March 4, 2021
Accolade Completes Acquisition of 2nd.MD
The combination brings together advocacy, benefits navigation, and expert medical opinion to elevate the member experience by creating the most comprehensive, integrated healthcare navigation experience. SEATTLE, March 04, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc.
Additional Formats
February 16, 2021
Accolade to Participate in Upcoming Investor Conferences
SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the following upcoming investor
Additional Formats
January 27, 2021
Accolade Welcomes Cindy R. Kent to its Board of Directors
Business leader, healthcare executive and one of Savoy Magazine's 2020 leading executives is driving positive change for the healthcare experience in the U.S. SEATTLE , Jan. 27, 2021 /PRNewswire/ --   Accolade (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help
Additional Formats
January 14, 2021
Accolade to Acquire 2nd.MD
The addition of 2nd.MD’s Expert Medical Opinion services to Accolade’s portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade’s clinical capabilities and creates the market’s most comprehensive, integrated healthcare navigation experience. SEATTLE, Jan.
Additional Formats
Displaying 11 - 20 of 22

Search Investor Relations